Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             55 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 All-trans-retinoic acid enhances apoptosis induction by tyrosine kinase inhibitors in the eosinophilic leukemia-derived EoL-1 cell line Robert, Carine
 2008
 32 Supplement 1 p. 343-346
4 p.
 artikel
2 A multiplex PCR for improved detection of typical and atypical BCR–ABL fusion transcripts Burmeister, Thomas
 2008
 32 Supplement 1 p. 579-585
7 p.
 artikel
3 Analysis of apoptosis regulatory genes expression in the bone marrow (BM) of adult de novo Myelodysplastic Syndromes (MDS) Economopoulou, C.
 2008
 32 Supplement 1 p. 61-69
9 p.
 artikel
4 Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma Bohling, Sandra D.
 2008
 32 Supplement 1 p. 383-393
11 p.
 artikel
5 Association of some rare haplotypes and genotype combinations in the MDR1 gene with childhood acute lymphoblastic leukaemia Semsei, Ágnes F.
 2008
 32 Supplement 1 p. 1214-1220
7 p.
 artikel
6 A unique case of IgD-only splenic marginal-zone lymphoma with mutated immunoglobulin genes: Ontogenetic implications Papadaki, Theodora
 2008
 32 Supplement 1 p. 155-157
3 p.
 artikel
7 Bone marrow fibroblasts induce expression of PI3K/NF-κB pathway genes and a pro-angiogenic phenotype in CLL cells Edelmann, J.
 2008
 32 Supplement 1 p. 1565-1572
8 p.
 artikel
8 Bone marrow pre-B expansion by SL/Kh-Bomb1 locus: Not sufficient for lymphomagenesis Hiratsuka, Takuya
 2008
 32 Supplement 1 p. 309-314
6 p.
 artikel
9 CD45 expression in low-grade B-cell non-Hodgkin's lymphomas Carulli, Giovanni
 2008
 32 Supplement 1 p. 263-267
5 p.
 artikel
10 Chromosome 5q deletion: Specific diagnoses and cytogenetic details among 358 consecutive cases from a single institution Santana-Davila, Rafael
 2008
 32 Supplement 1 p. 407-411
5 p.
 artikel
11 Clinicopathologic features and treatment outcome of primary breast diffuse large B-cell lymphoma Niitsu, Nozomi
 2008
 32 Supplement 1 p. 1837-1841
5 p.
 artikel
12 Cytogenetic abnormalities in Tunisian de novo myelodysplastic syndrome: A comparison with other populations Gmidène, Abir
 2008
 32 Supplement 1 p. 1824-1829
6 p.
 artikel
13 Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy Chien, Ju-Huei
 2008
 32 Supplement 1 p. 1724-1734
11 p.
 artikel
14 Dexamethasone increases ubiquitin transcription through an SP-1 dependent mechanism in multiple myeloma cells Mao, Xinliang
 2008
 32 Supplement 1 p. 1480-1482
3 p.
 artikel
15 dup(1)(q21q32) as a sole cytogenetic event is associated to a leukemic transformation in Myelodysplastic Syndromes Alfaro, Ramona
 2008
 32 Supplement 1 p. 159-161
3 p.
 artikel
16 Editorial Board 2008
 32 Supplement 1 p. CO2-
1 p.
 artikel
17 Editorial Board 2008
 32 Supplement 1 p. CO2-
1 p.
 artikel
18 Editorial board and publication information 2008
 32 Supplement 1 p. CO2-
1 p.
 artikel
19 Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias Serrano, Elena
 2008
 32 Supplement 1 p. 944-953
10 p.
 artikel
20 Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia Hou, Hsin-An
 2008
 32 Supplement 1 p. 904-912
9 p.
 artikel
21 Expression of the GPI-anchored receptor Prv-1 enhances thrombopoietin and IL-3-induced proliferation in hematopoietic cell lines Dillon, Megan
 2008
 32 Supplement 1 p. 811-819
9 p.
 artikel
22 Frequent microsatellite instability in non-Hodgkin lymphomas irresponsive to chemotherapy Miyashita, Kaname
 2008
 32 Supplement 1 p. 1183-1195
13 p.
 artikel
23 Functional analysis of myelodysplastic syndromes-derived mesenchymal stem cells Flores-Figueroa, Eugenia
 2008
 32 Supplement 1 p. 1407-1416
10 p.
 artikel
24 Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years Candoni, Anna
 2008
 32 Supplement 1 p. 1800-1808
9 p.
 artikel
25 Genomic variation at the MDR1 promoter and P-glycoprotein expression and activity in AML patients Lourenço, J.J.
 2008
 32 Supplement 1 p. 976-979
4 p.
 artikel
26 Glutathione S-transferases (GSTT1 and GSTM1) genes polymorphisms and the treatment response and prognosis in Chinese patients with de novo acute myeloid leukemia Xiao, Zhijian
 2008
 32 Supplement 1 p. 1288-1291
4 p.
 artikel
27 Heterodimer formation of the myeloid zinc finger 1 SCAN domain and association with promyelocytic leukemia nuclear bodies Noll, LeAnne
 2008
 32 Supplement 1 p. 1582-1592
11 p.
 artikel
28 High incidence of tuberculosis after alemtuzumab treatment in Hong Kong Chinese patients Au, Wing-Yan
 2008
 32 Supplement 1 p. 547-551
5 p.
 artikel
29 Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor κB Nishioka, Chie
 2008
 32 Supplement 1 p. 287-296
10 p.
 artikel
30 Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: Role of COX-2 and MDR-1 Arunasree, Kalle M.
 2008
 32 Supplement 1 p. 855-864
10 p.
 artikel
31 Impact of socioeconomic status and distance from treatment center on survival in patients receiving remission induction therapy for newly diagnosed acute myeloid leukemia Rodriguez, Cristina P.
 2008
 32 Supplement 1 p. 413-420
8 p.
 artikel
32 Inhibitory effect of the substance P and its derivative on erythropoietin-independent growth of erythroid progenitors in polycythemia vera Le Gall, Christelle
 2008
 32 Supplement 1 p. 743-754
12 p.
 artikel
33 Is substance P central to the biology of acute lymphoblastic leukemia? Rameshwar, Pranela
 2008
 32 Supplement 1 p. 3-4
2 p.
 artikel
34 Lethality to leukemia cell lines of DNA interstrand cross-links generated by Cloretazine derived alkylating species Penketh, Philip G.
 2008
 32 Supplement 1 p. 1546-1553
8 p.
 artikel
35 Matrix metalloproteinases-1 and -2, and tissue inhibitor of metalloproteinase-2 production is abnormal in bone marrow stromal cells of multiple myeloma patients Zdzisińska, Barbara
 2008
 32 Supplement 1 p. 1763-1769
7 p.
 artikel
36 Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia Giovannetti, Elisa
 2008
 32 Supplement 1 p. 19-24
6 p.
 artikel
37 Multiple myeloma cells directly stimulate bone resorption in vitro by down-regulating mature osteoclast apoptosis El Hajj Dib, Iman
 2008
 32 Supplement 1 p. 1279-1287
9 p.
 artikel
38 Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes Warlick, Erica D.
 2008
 32 Supplement 1 p. 1439-1447
9 p.
 artikel
39 Neuropilin-1 is expressed by chronic lymphocytic leukemia B cells Nowakowski, Grzegorz S.
 2008
 32 Supplement 1 p. 1634-1636
3 p.
 artikel
40 Newly diagnosed multiple myeloma: making the right treatment choices 2008
 32 Supplement 1 p. S3-S11
9 p.
 artikel
41 Peripheral blood cytogenetic studies in myelofibrosis: Overall yield and comparison with bone marrow cytogenetic studies Hussein, Kebede
 2008
 32 Supplement 1 p. 1597-1600
4 p.
 artikel
42 Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML Walker, Alison R.
 2008
 32 Supplement 1 p. 1830-1836
7 p.
 artikel
43 Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome Knipp, Sabine
 2008
 32 Supplement 1 p. 33-37
5 p.
 artikel
44 Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): Clinicopathologic comparison of del(5q)-positive and -negative cases Santana-Davila, Rafael
 2008
 32 Supplement 1 p. 1927-1930
4 p.
 artikel
45 PU.1 is dispensable to block erythroid differentiation in Friend erythroleukemia cells Fernández-Nestosa, María José
 2008
 32 Supplement 1 p. 121-130
10 p.
 artikel
46 Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resorptive activity in clinically relevant conditions Boissy, P.
 2008
 32 Supplement 1 p. 1661-1668
8 p.
 artikel
47 Roles of p15Ink4b and p16Ink4a in myeloid differentiation and RUNX1-ETO-associated acute myeloid leukemia Ko, Rose M.
 2008
 32 Supplement 1 p. 1101-1111
11 p.
 artikel
48 SCANning for PML nuclear bodies with Myeloid Zinc Finger 1 Gallagher, Robert E.
 2008
 32 Supplement 1 p. 1650-1652
3 p.
 artikel
49 Src family kinases promote AML cell survival through activation of signal transducers and activators of transcription (STAT) Ozawa, Yukiyasu
 2008
 32 Supplement 1 p. 893-903
11 p.
 artikel
50 Subcutaneous alemtuzumab for Sézary Syndrome in the very elderly Alinari, Lapo
 2008
 32 Supplement 1 p. 1299-1303
5 p.
 artikel
51 Successful radiotherapy in a patient with primary rectal mucosa-associated lymphoid tissue lymphoma without the API2-MALT1 fusion gene: A case report and review of the literature Kobayashi, Taisuke
 2008
 32 Supplement 1 p. 173-175
3 p.
 artikel
52 Successful treatment of extramedullary gastric plasmacytoma with the combination of bortezomib and dexamethasone: First reported case Katodritou, Eirini
 2008
 32 Supplement 1 p. 339-341
3 p.
 artikel
53 The aorta-gonad-mesonephros-derived stroma cell line DAS104-4 induces differentiation of leukemic cells Pramanik, Kallal
 2008
 32 Supplement 1 p. 781-789
9 p.
 artikel
54 Thrombospondin-1 (TSP-1) and Survivin (S) expression in non-Hogkin's lymphomas Paydas, Semra
 2008
 32 Supplement 1 p. 243-250
8 p.
 artikel
55 WT1 protein expression in slowly proliferating myeloid leukemic cell lines is scarce throughout the cell cycle with a minimum in G0/G1 phase Kerst, Gunter
 2008
 32 Supplement 1 p. 1393-1399
7 p.
 artikel
                             55 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland